Commercial Strategy and Product Differentiation

Tessellon has partnered with Bridge Consulting, a company specializing in optimizing commercial strategy for the biotech industry. The company’s founder and owner, Russ Belden, has over 25 years of industry experience, including 16 at Genentech as a business lead and sales director.

Bridge Consulting

Why Choose Tessellon and Bridge?

  • Product Differentiation
    Gain that edge in your product market share through launch plan fine tuned to market needs with a partner who thoroughly understands how to differentiate your product.
  • Portfolio planning
    Assess the value of your portfolio early in development and align with your commercialization strategy to invest in the right products/indications and have a solid market plan.
  • Licensing and partner opportunity assessments
    Obtain 3rd party analysis of revenue potential and commercial viability, risk assessment and market planning for licensing and partner opportunities.

Strategic Forecasting